Endocrinology and Dialysis Jean L. Holley, Series Editor: Osteoporosis and Chronic Kidney Disease
- 11 July 2007
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 20 (5), 423-430
- https://doi.org/10.1111/j.1525-139x.2007.00319.x
Abstract
Osteoporosis (OP), the most frequent bone disease affecting the general population, is associated with high fracture risk. Patients with impaired kidney function have bone and mineral disturbances leading to extraskeletal calcifications and complex changes in bone turnover that predispose them to increased fracture risk accompanied by increased morbidity and mortality. The combination of these two bone disorders seems to have an additive effect with regard to fracture risk and its outcome, so that appropriate diagnosis and treatment of this disorder should be of primary concern when approaching patients with kidney disease. Nevertheless, the clinical and laboratory diagnostic tools used to identify OP in the general population do not suit the requirement for detecting the complex bone and metabolic changes that occur with chronic kidney disease, leading to the lack of or the initiation of inappropriate therapy. This review will focus on the bone pathophysiologic processes involved in OP and renal osteodystrophy and address some of the problems associated with our current diagnostic tools and aspects of the therapeutic approaches.This publication has 89 references indexed in Scilit:
- Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hipJournal of Internal Medicine, 2006
- Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosisMedical Hypotheses, 2004
- Association of ?2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levelsHuman Genetics, 2004
- Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settingsNephrology Dialysis Transplantation, 2004
- Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremiaKidney International, 2003
- Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic FracturesJournal of Bone and Mineral Research, 2002
- Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease?Journal of the American College of Cardiology, 2002
- High Extracellular Calcium Concentrations Directly Stimulate Osteoclast ApoptosisBiochemical and Biophysical Research Communications, 2000
- High Extracellular Calcium Inhibits Osteoclast-like Cell Formation by Directly Acting on the Calcium-Sensing Receptor Existing in Osteoclast Precursor CellsBiochemical and Biophysical Research Communications, 1999
- Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTHKidney International, 1995